Guidelines - Page 11 of 17 Posts on Medivizor
Navigation Menu

Guidelines Posts on Medivizor

Invasive breast cancer: a review

Posted by on Aug 9, 2016 in Breast cancer | 0 comments

In a nutshell This review outlined the recommended treatment options for invasive breast cancer.  Some background Breast cancer is the most commonly diagnosed cancer in the world and it is the leading cause of cancer-related death in women. Breast cancer often begins in the milk ducts and lobules. In invasive breast cancer, the cancer moves...

Read More

Treating NSCLC in clinical practice

Posted by on Jul 2, 2016 in Lung cancer | 0 comments

In a nutshell This review aimed to provide updated guidelines on treating non-small-cell lung cancer depending on the genetic profile of the cancer. The authors conclude that in certain types of cancers with genetic mutations (changes) drugs aimed at the specific mutation could be more beneficial than chemotherapy and other treatments. Some background...

Read More

Management of high blood pressure and high heart rate

Posted by on Jul 2, 2016 in Hypertension | 0 comments

In a nutshell This paper looked at the management of patients with high blood pressure and elevated heart rate. An elevated heart rate increases the risk of heart disease.  Some background A meeting by a panel of experts of the European Society of Hypertension examined the issue of elevated heart rate in patients with high blood pressure....

Read More

Treatment guidelines for metastatic colorectal cancer patients with RAS mutation

Treatment guidelines for metastatic colorectal cancer patients with RAS mutation

Posted by on Jun 27, 2016 in Colorectal cancer | 0 comments

In a nutshell In this study, the American Society of Clinical Oncology Provisional Clinical Opinion (PCO) updated recommendations for treating metastatic (spread to other organs) colorectal cancer patients with RAS gene mutation. Some background RAS mutation (change) is one of the most common in colorectal tumors. This mutation can affect the...

Read More

Updated guidelines for the treatment of stage IV NSCLC

Updated guidelines for the treatment of stage IV NSCLC

Posted by on May 30, 2016 in Lung cancer | 0 comments

In a nutshell The American Society of Clinical Oncology (ASCO) gathered a panel of experts to update guidelines on systemic therapy (such as chemotherapy) for stage 4 non-small cell lung cancer (NSCLC). They provided updated guidelines with recommendations for first, second and third-line systemic therapy as well as targeted therapy.  Some...

Read More

Stereotactic ablative radiotherapy for treating NSCLC

Stereotactic ablative radiotherapy for treating NSCLC

Posted by on May 21, 2016 in Lung cancer | 0 comments

In a nutshell This study aimed to assess the effectiveness of stereotactic ablative radiotherapy (SABR) treatment in patients with second primary lung cancer and whether CT surveillance would be beneficial to these patients. The review concluded that SABR is an effective treatment in patients with early stage NSCLC who are unable to undergo surgery....

Read More

Updated guidelines for treating small-cell lung cancer

Updated guidelines for treating small-cell lung cancer

Posted by on May 9, 2016 in Lung cancer | 0 comments

In a nutshell The American Society of Clinical Oncology (ASCO) reviewed guidelines for the treatment of small cell lung cancer (SCLC), developed by the American College of Chest Physicians (ACCP).  Some background Guidelines for the treatment of SCLC were established by ACCP in 2013. Based on scientific evidence, a panel of experts put...

Read More